Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Prilosec receives positive recommendation for OTC status

Oct. 24, 2000

Encouraging data reported for Emitasol in diabetic gastroparesis

Oct. 23, 2000

IND for hepatitis C gene fusion therapy submitted by Human Genome Sciences

Oct. 20, 2000

IBS treatment launched in Japan by Hokuriku and Fujisawa

Oct. 19, 2000

Phase III trial reveals potency of H. pylori treatment

Oct. 19, 2000

Effects of repeated doses of YF-476 on gastric pH examined in healthy volunteers

Oct. 17, 2000

A20 protein found to be key mediator of inflammatory processes

Oct. 11, 2000

Preclinical data support clinical trials of repifermin in ulcerative colitis

Oct. 10, 2000

NitroMed's newest NO- and/or NO2-containing proton pump inhibitors

Oct. 9, 2000

Ribozyme repurchases rights to Heptazyme; phase II trial to begin

Oct. 9, 2000

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...